Literature DB >> 22226904

HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.

C M Corcoran1, C Smith, D McLaughlin, A Auther, D Malaspina, B Cornblatt.   

Abstract

BACKGROUND: Stress sensitivity and HPA axis activity may be relevant to the development and expression of psychotic disorders. Cortisol secretion has been associated with positive symptoms both in patients with psychotic disorders and in young people at clinical risk for psychosis. Herein, we aimed to replicate these findings, to determine which positive symptoms may be associated with cortisol levels, and to explore any associations with affective symptoms and impaired stress tolerance.
METHODS: Thirty-one clinical high risk patients were evaluated in cross-section for associations between salivary cortisol levels upon clinic entry at 11 am, demographic variables, and clinical symptoms.
RESULTS: Salivary cortisol levels were unrelated to medication exposure or demographics, except for higher levels in the ten females studied. Salivary cortisol bore no relationship to overall positive symptom severity but was associated with anxiety, as well as with suspiciousness and impaired stress tolerance, which were themselves highly intercorrelated.
CONCLUSIONS: Cortisol secretion in the context of a putative novel social situation (i.e. clinic entry) may be a biological correlate of suspiciousness, impaired stress tolerance and affective symptoms in individuals vulnerable to developing psychosis. These associations are consistent with findings from experience sampling studies in individuals at risk for psychosis as well as basic studies of animal models of schizophrenia.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226904      PMCID: PMC3716011          DOI: 10.1016/j.schres.2011.11.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

1.  A cognitive model of the positive symptoms of psychosis.

Authors:  P A Garety; E Kuipers; D Fowler; D Freeman; P E Bebbington
Journal:  Psychol Med       Date:  2001-02       Impact factor: 7.723

2.  Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.

Authors:  Elaine F Walker; Patricia A Brennan; Michelle Esterberg; Joy Brasfield; Brad Pearce; Michael T Compton
Journal:  J Abnorm Psychol       Date:  2010-05

Review 3.  Stress-reactivity in psychosis: evidence for an affective pathway to psychosis.

Authors:  Inez Myin-Germeys; Jim van Os
Journal:  Clin Psychol Rev       Date:  2007-01-10

Review 4.  Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.

Authors:  Ruud van Winkel; Nicholas C Stefanis; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

5.  Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.

Authors:  D J Walder; E F Walker; R J Lewine
Journal:  Biol Psychiatry       Date:  2000-12-15       Impact factor: 13.382

Review 6.  Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.

Authors:  M Laruelle; A Abi-Dargham
Journal:  J Psychopharmacol       Date:  1999-12       Impact factor: 4.153

7.  The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2005-11-23       Impact factor: 7.853

8.  Does reactivity to stress cosegregate with subclinical psychosis? A general population twin study.

Authors:  T Lataster; M Wichers; N Jacobs; R Mengelers; C Derom; E Thiery; J Van Os; I Myin-Germeys
Journal:  Acta Psychiatr Scand       Date:  2008-09-19       Impact factor: 6.392

9.  Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.

Authors:  Alexandra Soliman; Gillian A O'Driscoll; Jens Pruessner; Anne-Lise V Holahan; Isabelle Boileau; Danny Gagnon; Alain Dagher
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

10.  Subtle gene-environment interactions driving paranoia in daily life.

Authors:  C J P Simons; M Wichers; C Derom; E Thiery; I Myin-Germeys; L Krabbendam; J van Os
Journal:  Genes Brain Behav       Date:  2008-08-21       Impact factor: 3.449

View more
  38 in total

1.  Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.

Authors:  Lawrence H Yang; Bruce G Link; Shelly Ben-David; Kelly E Gill; Ragy R Girgis; Gary Brucato; Ahtoy J Wonpat-Borja; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2015-08-25       Impact factor: 4.939

2.  Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review.

Authors:  Samantha L Redman; Cheryl M Corcoran; David Kimhy; Dolores Malaspina
Journal:  Arch Psychol (Chic)       Date:  2017-12-18

3.  Developmental timing and critical windows for the treatment of psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

Review 4.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

5.  Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.

Authors:  Tyler B Grove; Ivy F Tso; Jinsoo Chun; Savanna A Mueller; Stephan F Taylor; Vicki L Ellingrod; Melvin G McInnis; Patricia J Deldin
Journal:  Psychiatry Res       Date:  2016-06-25       Impact factor: 3.222

6.  Stress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries.

Authors:  Jordan E DeVylder; Ai Koyanagi; Jay Unick; Hans Oh; Boyoung Nam; Andrew Stickley
Journal:  Schizophr Bull       Date:  2016-04-24       Impact factor: 9.306

Review 7.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

8.  Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.

Authors:  Marilena Colaianna; Stefania Schiavone; Margherita Zotti; Paolo Tucci; Maria Grazia Morgese; Liselotte Bäckdahl; Rikard Holmdahl; Karl-Heinz Krause; Vincenzo Cuomo; Luigia Trabace
Journal:  Antioxid Redox Signal       Date:  2013-04-20       Impact factor: 8.401

9.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

Review 10.  The influence of stress at puberty on mood and learning: role of the α4βδ GABAA receptor.

Authors:  S S Smith
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.